Adjuvants are critical for improving the quality and magnitude of adaptive immune responses
to vaccination. Lipid nanoparticle (LNP)-encapsulated nucleoside-modified mRNA …

The deployment of effective vaccines against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) is critical to eradicate the coronavirus disease 2019 (COVID-19) pandemic…

SARS-CoV-2 infection has emerged as a serious global pandemic. Because of the high
transmissibility of the virus and the high rate of morbidity and mortality associated with COVID-19…

Vaccine-mediated immunity often relies on the generation of protective antibodies and
memory B cells, which commonly stem from germinal center (GC) reactions. An in-depth …

The vast majority of currently licensed human vaccines work on the basis of long-term
protective antibody responses. It is now conceivable that an antibody-dependent HIV vaccine …

Millions of people are suffering from Long COVID or post-acute sequelae of COVID-19 (PASC).
Several biological factors have emerged as potential drivers of PASC pathology. Some …

To successfully protect against pathogen infection, a vaccine must elicit efficient adaptive
immunity, including B and T cell responses. While B cell responses are key, as they can …

Follicular helper CD4 T (Tfh) cells provide B cells with signals that are important for the
generation of high-affinity Abs and immunological memory and, therefore, are critical for the …

T-follicular helper (Tfh) cells differentiate through a multistep process, culminating in
germinal center (GC) localized GC-Tfh cells that provide support to GC-B cells. T-follicular …

Humans and mice deficient in the adaptor protein SAP (Sh2d1a) have a major defect in
humoral immunity, resulting from a lack of T cell help for B cells. The role of SAP in this process …